Stabilization & Maintenance

This toolkit is tailored specifically to the unique needs of multidisciplinary substance use disorder (SUD) providers and programs serving perinatal individuals. It is meant to be a quick reference resource about mental health and SUD specific to perinatal individuals.

The Drug Free Moms and Babies (DFMB) Project is a comprehensive and integrative medical and behavioral health program for pregnant and postpartum women. The project supports healthy baby outcomes by providing prevention, early intervention, addiction treatment, and recovery support services.

UNC Horizons is a substance use disorder treatment program for women, including those who are pregnant, parenting, and/or whose lives have been touched by abuse and violence.

The Project RESPECT team supports patients throughout their recovery journey during the entire first year postpartum and offer monitored, acute substance withdrawal treatment and induction of medications for opioid use disorder in pregnant patients seeking treatment.

Moms in Recovery is a program for pregnant and parenting women who struggle with substance use, and form close relationships with counselors, psychiatrists, midwives, pediatricians, case managers and recovery coaches.

MaineMOM aims to improve care for pregnant and postpartum people with opioid use disorder and their infants by integrating maternal and substance use treatment services.

This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.

A new webinar series from the National Academy of Medicine (NAM) and the American Society of Addiction Medicine (ASAM) providing insight and targeted guidance on how to ensure that people with addiction are cared for and protected during the COVID-19 public health crisis.